Effect of Caralluma tuberculata on regulation of carbohydrate metabolizing genes in alloxan-induced rats

J Ethnopharmacol. 2021 May 10:271:113897. doi: 10.1016/j.jep.2021.113897. Epub 2021 Feb 7.

Abstract

Ethnopharmacological relevance: Caralluma tuberculata (C. tuberculata) has traditionally been used in Pakistan and other parts of the world as a folk treatment for diabetes mellitus. A few studies indicated its antihyperglycemic effect, however, the mystery remained unfolded as how did it modify the pathophysiological condition.

Aim of study: Hence, this study aimed to explore underlying mechanism(s) for its hypoglycemic activity at biochemical and molecular levels.

Materials and methods: Methanol extract (ME) of C. tuberculata as well as its hexane (HF) and aqueous (AF) fractions were explored for their effect on total glycogen in liver and skeletal muscle of alloxan-induced rats by spectroscopy. Moreover, the expression of genes related to hepatic carbohydrate metabolizing enzymes was quantified. At molecular level, mRNA expression of glucose transporter 2 (GLUT-2), glycogen synthase (GS), glucokinase (GK), hexokinase 1 (HK-1), pyruvate kinase (PK), glucose 6 phosphate dehydrogenase (G-6-PDH), pyruvate carboxylase (PC), phosphoenolpyruvate carboxykinase (PEPCK) and glucose 6 phosphatase (G-6-Pase) was determined by using quantitative real time polymerase chain reaction (qRT-PCR) after administration of ME (350 mg), HF(3 mg), AF (10 mg) and metformin (500 mg). The doses were administered twice daily according to per kg of body weight.

Results: A significant reduction in hepatic and skeletal muscle glycogen content was exhibited. The data of qRT-PCR revealed that gene's expression of GLUT-2 was significantly decreased after treatment with ME and HF, whilst it was unaltered by AF, however, a significant decrease was observed in genes corresponding to GS, GK and HK-1 after treatment with ME. Similarly, there was a significant decrease in expression of genes corresponding to GS, GK and HK-1 following treatment with HF. Surprisingly, post-treatment with AF didn't modify the gene's expression of GS and GK, whilst it caused a profound decrease in expression of HK-1 gene. Contrarily, the expression of gene related to PK was significantly up-regulated post-administration with ME, HF and AF. The expression levels of G-6-PDH, however, remained unaltered after treatment with the experimental extract and fractions of the plant. In addition, HF and AF did not cause any modification in PEPCK, whereas ME caused a significant down-regulation of the gene. Treatment with all the extract and fractions of the plant caused a substantial decrease in the gene's expression of PC, while there was a significant increase in the expression of gene related to G-6-Pase.

Conclusion: The three experimental extract and fractions caused a substantial decrease in glycogen content in liver and skeletal muscle tissues. The analysis by qRT-PCR showed that glucose transport via GLUT-2 was profoundly declined by ME and HF. The expression of genes related to various metabolic pathways involved in metabolism of carbohydrate in hepatocytes revealed explicitly that the ME, HF and AF decreased the phenomena of glycogenesis and gluconeogenesis. Contrarily, all the extract and fractions of the plant activated glycogenolysis and glycolysis but did not modify the pentose phosphate shunt pathway.

Keywords: Caralluma tuberculata; Carbohydrate metabolizing enzymes; Glycogen; Quantitative real time polymerase chain reaction.

MeSH terms

  • Alloxan / toxicity
  • Animals
  • Apocynaceae / chemistry*
  • Blood Glucose / drug effects
  • Carbohydrate Metabolism / drug effects*
  • Carbohydrate Metabolism / genetics*
  • Diabetes Mellitus, Experimental / drug therapy*
  • Diabetes Mellitus, Experimental / metabolism
  • Glucokinase / genetics
  • Glucose Transporter Type 2 / genetics
  • Glucose-6-Phosphatase / genetics
  • Glucosephosphate Dehydrogenase / genetics
  • Glycogen / metabolism
  • Glycogen Synthase / genetics
  • Hexanes / chemistry
  • Hexokinase / genetics
  • Hypoglycemic Agents / pharmacology*
  • Hypoglycemic Agents / therapeutic use
  • Intracellular Signaling Peptides and Proteins / genetics
  • Liver / drug effects
  • Liver / enzymology
  • Methanol / chemistry
  • Muscle, Skeletal / drug effects
  • Phosphoenolpyruvate Carboxykinase (GTP) / genetics
  • Plant Extracts / pharmacology*
  • Plant Extracts / therapeutic use
  • Pyruvate Carboxylase / genetics
  • Pyruvate Kinase / genetics
  • Rats
  • Rats, Wistar
  • Water / chemistry

Substances

  • Blood Glucose
  • Glucose Transporter Type 2
  • Hexanes
  • Hypoglycemic Agents
  • Intracellular Signaling Peptides and Proteins
  • Plant Extracts
  • Slc2a2 protein, rat
  • Water
  • Alloxan
  • Glycogen
  • Glucosephosphate Dehydrogenase
  • Glycogen Synthase
  • Hexokinase
  • Glucokinase
  • Pyruvate Kinase
  • Glucose-6-Phosphatase
  • Pck1 protein, rat
  • Phosphoenolpyruvate Carboxykinase (GTP)
  • Pyruvate Carboxylase
  • Methanol